NYSE:PFE

Pfizer Inc (PFE)

27.75
+0.03 (0.11%)
as of Sep 14, 2026, 5:42:20 pm Market Open.
583 watching
0
Investor Insights
star iconSep 14, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Pfizer Inc. (PFE) is perceived as a defensive stock with an attractive dividend yield around 6-7%, appealing to income-focused investors. However, many experts express concern about the company's growth potential following a reliance on COVID-19 vaccine revenues, which have receded. The consensus indicates that while PFE maintains a low valuation (PE around 8-10x), its growth is stagnant or uncertain due to impending patent expirations and the challenges associated with developing new blockbuster drugs. Moreover, there are worries that the ongoing focus on acquisitions may not lead to the anticipated revenue boosts. Despite these concerns, some analysts suggest PFE could still perform well for patient investors, especially as sector interest begins to build. Ultimately, the outlook remains cautious, with a preference noted for other stocks in the pharmaceutical sector that exhibit better growth trajectories.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Undervalued
review icon
Similar
LLY
BUY
Not doing much, but a good stock to own.
BUY
Likes the pharmaceutical group. Acquisition of Pharmacia is positive.
BUY
Likes. Great value.
HOLD
Good merger made. Good company.
BUY
Positive on the drug industry.
BUY
Strong pipeline. Republican win is good for pharmaceuticals.
BUY
Should start to see a rise.
BUY
Top quality company. Cheap. Good sector for the long term.
BUY
Sector has been hit hard. A very liquid stock.
DON'T BUY
Governments are trying to cut health care costs. Sector seems to be weak.
BUY
US pharmaceutical sector is very cheap now.
TOP PICK
Trading at less than 20 X earnings. Reasonable dividend yield. Have some new products in the pipeline.
BUY
Looks good.
TOP PICK
Likes the valuations. Good balance sheet and good earnings. Made some good acquisitions.
HOLD
Fair market value is more than share price.
Showing 796 to 810 of 890 entries